The Latest Resources for Clinical Developments and Insights

The Latest Resources for Clinical Developments and Insights

We’re ushering in a new generation of clinical discovery with resources to match. Catch up with the thought leaders at Clinical ink, learn more about our technology solutions, and stay up-to-date with the latest industry news. Access our library of resources, including blogs, events, whitepapers, and more.

Latest from the Newsroom

Clinical ink announces an integrated suite of eClinical tools for cardiometabolic clinical trials.

The article emphasizes key considerations like ensuring terminological clarity to prevent misunderstandings, the importance of transparency in communication, and how these factors collectively influence stakeholder understanding and acceptance.

This article describes how behavioral science can be applied in cardiometabolic clinical research to augment drug interventions. This combined approach addresses the Health Inequity gap while also increasing patient engagement.

The recent FDA publication "Submitting Patient-Reported Outcome (PRO) Data in Cancer Clinical Trials'' represents a significant leap forward in cancer research and drug development. This detailed guidance for integrating PROs into the drug approval process sets a new standard for the evaluation of cancer treatments.

Scroll to Top